Curesearch For Childrens Cancer
- Assets
- $8.0m
- Revenue
- $6.1m
- Investments
- $0.0
- Employees
- 23
- Location
- Bethseda, MD
- Founding
- 04/1992
- Data as of
- 12/2023
- EIN
- 95-4132414
Organization Overview
Curesearch For Childrens Cancer is located in Bethseda, MD. The organization was established in 1992. According to its NTEE Classification (G11) the organization is classified as: Single Organization Support, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2023, Curesearch For Childrens Cancer employed 23 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Curesearch For Childrens Cancer is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Curesearch For Childrens Cancer generated $6.1m in total revenue. The organization has seen a slow decline revenue. Over the past 9 years, revenues have fallen by an average of (0.4%) each year. All expenses for the organization totaled $4.9m during the year ending 12/2023. As we would expect to see with falling revenues, expenses have declined by (3.1%) per year over the past 9 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Curesearch For Childrens Cancer has awarded 111 individual grants totaling $14,816,642. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
CURESEARCH FUNDS & SUPPORTS CHILDREN'S CANCER RESEARCH & PROVIDES EDUCATION & RESOURCES TO ALL THOSE AFFECTED BY CHILDREN'S CANCER.
Describe the Organization's Program Activity:
Part 3 - Line 4a
WE ANNOUNCED THREE GROUNDBREAKING NEW PROJECTS FOCUSED ON PEDIATRIC BONE, BLOOD, AND BRAIN CANCERS WHERE NEW THERAPIES ARE UGENTLY NEEDED.
WE PARTNERED WITH FIVE PEDIATRIC CANCER ORGANIZATIONS AND SUPPORTERS THIS YEAR TO ESTABLISH THE $1.5 MILLION "FIGHTING OSTEOSARCOMA TOGETHER SUPER GRANT". THIS PROJECT FUNDS HIGH-IMPACT OSTEOSARCOMA RESEARCH DESPERATELY NEEDED TO CHANGE THE CURRENT DECADES-OLD STANDARD OF CARE.
WE SPEARHEADED A NEW STUDY TO DETERMINE HOW MOLECULAR TESTING CAN GUIDE TREATMENT DECISIONS AND LOWER COSTS FOR CHILDHOOD CANCER PATIENTS. COLLABORATIVE STUDIES LIKE THIS IMPROVE OUTCOMES FOR CHILDREN WITH CANCER.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Kay Koehler President And CEO | Officer | 40 | $400,641 |
Tiffani Copeland Cdo | Officer | 40 | $215,654 |
Tahira West Sr VP Finance & Operations | Officer | 40 | $162,541 |
Libby Fennell Sr Director Donor Development | Officer | 0 | $107,085 |
Jess Nicholson Sr Director Marketing | Officer | 0 | $93,325 |
Chase Carter Director Community Engagement | Officer | 0 | $4,981 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $3,749,597 |
| Noncash contributions included in lines 1a–1f | $285,246 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $3,749,597 |
| Total Program Service Revenue | $0 |
| Investment income | $111,374 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $48,731 |
| Net Income from Fundraising Events | $2,222,253 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $6,131,955 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $1,789,869 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $75,000 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $984,227 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $869,279 |
| Pension plan accruals and contributions | $27,745 |
| Other employee benefits | $161,961 |
| Payroll taxes | $124,415 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $2,688 |
| Fees for services: Accounting | $50,157 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $19,261 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $16,743 |
| Royalties | $0 |
| Occupancy | $15,138 |
| Travel | $65,652 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $109,455 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $66,496 |
| All other expenses | $104,373 |
| Total functional expenses | $4,882,330 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $2,194,857 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $1,930,335 |
| Accounts receivable, net | $80,638 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $37,189 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $3,758,934 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $8,001,953 |
| Accounts payable and accrued expenses | $163,239 |
| Grants payable | $0 |
| Deferred revenue | $59,300 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $222,539 |
| Net assets without donor restrictions | $1,542,243 |
| Net assets with donor restrictions | $6,237,171 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $8,001,953 |
Grants Awarded
Over the last fiscal year, Curesearch For Childrens Cancer has awarded $1,789,869 in support to 11 organizations.
| Grant Recipient | Amount |
|---|---|
AUGUSTA UNIVERSITY MEDICAL COLLEGE OF GEORGIA PURPOSE: THERAPEUTIC | $400,000 |
CONNECTICUT CHILDRENS MEDICAL CENTER PURPOSE: THERAPEUTIC | $75,000 |
UNIVERSITY OF COLORADO PURPOSE: THERAPEUTIC | $89,850 |
BAYLOR COLLEGE OF MEDICINE PURPOSE: THERAPEUTIC | $75,000 |
YALE UNIVERSITY PURPOSE: THERAPEUTIC | $149,019 |
ST BALDRICK'S FOUNDATION INC PURPOSE: THERAPEUTIC | $100,000 |